RX Ponder Clinical Trial?

pinkchicago
pinkchicago Member Posts: 15
edited May 2016 in ILC (Invasive Lobular Carcinoma)

Is anyone else participating in this clinical trial? I entered in December 2011 and I wonder the progress? I was diagnosed Stage 2, but had low onca score, so qualified for trial and was randomized with no chemotherapy. I had 33 treatments of radiation and I'm on tamoxifin. So far, I've been clean. Praying the good fortune continues.

· Share on FacebookShare on Twitter

Comments

  • JohnSmith
    JohnSmith Member Posts: 651
    edited May 2016

    For those unaware, RxPONDER is a randomized Phase III clinical trial of Endocrine Therapy plus or minus Chemotherapy in ER+, HER2- patients with 1-3 Positive Nodes, and a Oncotype score of 25 or less.
    Endocrine Therapy includes any of the following: Tamoxifen (Tam), Anastrozole (Arimidex), Letrozole (Femara), or Exemestane (Aromasin).

    It is not yet known whether giving Adjuvant Endocrine Therapy (Tam or AI's) is more effective with combination chemo in treating this population of patients.
    With over 1500 different locations throughout the world, this NCI sponsored trial is still enrolling and slated to continue for many more years.

    https://clinicaltrials.gov/ct2/show/NCT01272037
    Estimated Enrollment: 5000
    Study Start Date: January 2011
    Estimated Primary Completion Date: February 2022 (Final data collection date for primary outcome measure)

    · Share on FacebookShare on Twitter

Categories